Taking DCB technology to a New High

Drug-coated balloon (DCB) treatment is based on a leave-nothing-behind concept. DCB offers homogeneous drug delivery to the vessel wall, immediate drug release without the use of a polymer, the potential of reducing the intensity and duration of antiplatelet therapy, and the absence of residual foreign material in the vessel.

Manufactured by Blue Medical Devices B.V. in the Netherlands EU-MDR Certified

class="elementor-video" frameborder="0" allowfullscreen="" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" title="Protégé DEB Technology" width="640" height="360" src="https://www.youtube.com/embed/a2mIZPPladk?controls=1&rel=0&playsinline=0&cc_load_policy=0&autoplay=0&enablejsapi=1&origin=https%3A%2F%2Ftranslumina.com&widgetid=1&forigin=https%3A%2F%2Ftranslumina.com%2Fproducts%2Fdrug-eluting-balloon%2Fprotege-nc%2F&aoriginsup=1&gporigin=https%3A%2F%2Fwww.google.com%2F&vf=1" id="widget2" data-gtm-yt-inspected-8="true" style="box-sizing: border-box; border-width: initial; border-style: none; line-height: 1; margin: 0px; max-width: 100%; width: 798px; background-color: rgb(0, 0, 0); display: flex; height: 448.875px;">

Protégé is powered with technology offering patient benefits with maximum drug available at lesion site.

Introducing our innovative drug-coated balloon (DCB), Protégé with technology that ensures minimal drug loss during transition with patented technology.

 

Protégé is worlds 1st and only DCB Available in both semi-complaint and non-compliant version.

  • Linear Expansion with no over growth at high pressure
  • NC balloons minimize dissection in complex lesion subset compared to SC balloons*
  • For the treatment of ISR and lesions difficult to dilate
  • Higher strength than Semi-Compliant DCB**
The "Blue Medical Protege NC Paclitaxel Eluting Balloon (PTCA) 2.75 x 15" is a medical device used for percutaneous transluminal coronary angioplasty (PTCA). It's a non-compliant, drug-eluting balloon catheter designed to address coronary artery disease, specifically in cases of in-stent restenosis (ISR) or difficult-to-dilatate lesions. The device uses a high-pressure, non-compliant balloon with paclitaxel, a drug that helps prevent vessel re-narrowing, in the form of a drug-eluting balloon. 
Here's a more detailed breakdown:
  • Non-Compliant (NC):
    This means the balloon expands linearly and doesn't over-grow at high pressures. 
  • Drug-Eluting (DEB):
    The balloon has a coating that releases paclitaxel, a drug that inhibits cell growth and helps prevent restenosis (re-narrowing) of the treated vessel. 
  • Paclitaxel:
    This drug is specifically designed to target and inhibit the growth of vascular smooth muscle cells, which contribute to restenosis. 
  • PTCA:
    The device is used for PTCA, a minimally invasive procedure to open blocked or narrowed coronary arteries by using a balloon and catheter. 
  • 2.75 x 15:
    This refers to the dimensions of the balloon, with 2.75 being the balloon's diameter in millimeters and 15 being its length. 
  • Blue Medical:
    The device is manufactured by Blue Medical, a company specializing in vascular devices. 
Purpose of the device:
  • Treating in-stent restenosis (ISR).
  • Addressing lesions that are difficult to dilate.
  • Improving the success rate of PTCA procedures and reducing the need for subsequent procedures. 
Key benefits of the Protégé NC:
  • Combining the advantages of a high-pressure, non-compliant balloon with the therapeutic benefits of drug delivery. 
  • Providing a precise and powerful dilatation while delivering the drug. 
  • Maintaining the performance, profile, and flexibility of a standard PTCA balloon. 
In summary, the Blue Medical Protégé NC is a valuable tool for interventional cardiologists in treating coronary artery disease by using a high-pressure, non-compliant balloon to widen the vessel while delivering paclitaxel to prevent re-narrowing.